Participating Investors Include:
415 Capital
415 CAPITAL is a specialist venture capital firm that invests in early- and development-stage MedTech companies in Europe, the United States and Israel. We primarily invest in innovative medical device technologies addressing cardiovascular disease: the worldwide leading cause of death and the single largest cost driver in the global healthcare system. We are investors AND entrepreneurs: As investors, we have funded 45 MedTech companies in the past 28 years. As entrepreneurs, we have founded, built, and exited several successful European MedTech distribution companies.
1315 Capital
1315 Capital is a private investment firm with over $500 million under management that provides expansion and growth capital to commercial-stage healthcare services, medical technology, and specialty therapeutics companies. We target markets where high-quality management teams can rapidly scale platform companies into large and important businesses that positively impact patients, physicians, and the broader healthcare system.
Action Potential Venture Capital
Action Potential Venture Capital (APVC) is GSK's bioelectronic medicines venture fund. APVC is focused on the next generation of peripheral neuromodulation medical devices, and invests in companies and technologies that enable the future of targeted and adaptive bioelectronics.
Abingworth
Abingworth has raised 12 funds dedicated to investing in life sciences and healthcare. Our most recent, Abingworth Bioventures 7 and Abingworth Clinical Co-Development Fund, raised $315 million and $108 million respectively and are actively investing. Our venture funds invest across our broad strategic areas of venture capital, clinical co-development, VIPEs and public markets. They focus primarily on private companies but invest a percentage of their value in public companies.
AFC Advisors
*Description coming soon!
Ajax Health
AJAX Health accelerates medical innovation through capital and capabilities. Created in partnership with private equity leaders KKR and Aisling Capital, AJAX invests and takes an operating role in innovative medical companies that improve lives and bring speed, simplicity and cost efficiency to health care. AJAX is led by industry veteran Duke Rohlen and his trusted ecosystem of proven industry and operational experts. AJAX’s team has a proven track record of helping companies of all sizes, stages and structures achieve their value-creation goals.
Albion Capital
Albion Capital manages six VCTs which have assets of c.£440 million invested across c.65 companies. The Albion team invests anywhere between £250,000 and £12 million into high growth businesses in a wide range of sectors including Healthcare, Technology.
Amzak Health
Amzak’s investment activities in healthcare are managed by Majalin LLC, an independent firm led by Joyce Erony. Majalin is based in New York City and does business under the name “Amzak Health.” The Amzak Health principals have invested in over 50 healthcare companies since 2005. Amzak Health invests across the healthcare sector including therapeutics, devices, diagnostics and services. We size our investment based on the company’s needs, and seek to invest a minimum of $5 million for venture capital deals and up to $75 million or more for growth equity transactions. We invest in both private and public companies.
Aperture Venture Partners
Aperture Venture Partners is a healthcare-focused investment firm. We are committed to working with exceptional entrepreneurs to build innovative companies in the medical device, pharmaceutical, healthcare IT/services and diagnostic sectors. Our partners have deep industry knowledge and a track record of success in helping outstanding companies realize their potential.
Aphelion Capital
Aphelion Capital is a healthcare Venture Capital firm focused on bringing innovation and value to improve the lives of people globally. We invest in ideas and technologies that deliver better outcomes at the same or lower cost to the healthcare system.
Ascension Ventures
Ascension Ventures is a strategic healthcare venture fund with more than $800 million in capital under management. Our limited partners are some of the most respected, values-driven nonprofit healthcare systems in the US. As a strategic investor, Ascension Ventures adds value by sharing its portfolio companies' solutions across its limited partner base. The work we do at Ascension Ventures generates returns to our limited partners that help support their missions to provide care to the poor and vulnerable.
Atlantic Bridge
Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy with over €950 million of assets under management across seven Funds. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up and exploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.
Avestria Ventures
We define women’s health as conditions affecting women differently or disproportionately - and with women making 80% of household healthcare decisions and comprising 75% of the healthcare workforce, it’s not surprising to us that we meet so many female entrepreneurs with innovative health-related businesses. We seek out early stage businesses with a product or service that utilizes technology and/or data to improve the quality of healthcare, improve access, lower costs or empower patients. In order to achieve commercial success, these businesses must be evidenced-based, induce clinical or behavioral change, possess scalable commercialization plans which account for healthcare policy, reimbursement and the existing infrastructure, and possess a sustainable competitive advantage.
Baker & Eastlack Ventures
We invest in early stage medical devices and diagnostics. We prefer the founders have done a little work, filed the IP, and have a clear direction about product development, the FDA pathway, and clinical trials. This does not mean we will not work with companies at an earlier stage, as we are open to all great ideas.
Band of Angels
The Band reviews more than 1,000 deals per year. In 2019, the Band members invested in 27 startups. Obviously this is a competitive dynamic. Nevertheless, our goal is to provide as much value as we can to all companies that pitch the Band. Many companies that do not progress further in our process still benefit from it; especially those that make it to a Deal Dinner presentation. Reflecting the diverse career expertise of its membership the Band invests in ALL categories of seed technology deals and life sciences. We do not invest in real estate, restaurants, retail, or funds, but we do invest in agtech, blockchain, energy, fintech, hardware, life sciences/medtech, and software. Typically, the Band's investment is the first “organized” money into the company, either as a series Seed or Series A.
BayMed Venture Partners
BayMed Venture Partners is a dedicated life science venture capital fund based in the San Francisco Bay Area. The fund is focused on maturing early stage medical device and digital health companies located in North America and Israel. The fund intends to make initial investments in companies raising Series A or B rounds.
Biomark Capital
Biomark Capital provides venture funding and assistance to early, mid, and late-stage life science companies. We target companies with novel approaches to diagnostics, therapeutics, medical devices, and digital health that will change the face of healthcare innovation in the future. We share the drive and vision of our portfolio companies to collaborate with them in accelerating growth and building successful business ventures.
Broadview Ventures
Broadview is a mission-driven fund whose primary investment goal is to improve human health in the areas of cardiovascular disease and stroke. We define success – return on mission – as improving human health by bringing innovative technologies to patients. With 37 such investments over the past 9 years, Broadview has considerable experience in the seed/early-stage space, and its investment model is demonstrating early signs of success.
Capita3
Capita3 is an early stage venture capital fund investing in women startup founders and the companies they’re building. We’re leading the next generation of venture capital by investing in the growth of the startup CEO alongside our investment in the growth of the company, and we’ll set a new standard for how VC-financed companies grow and exit.
Cascara Ventures
Cascara Ventures is the new investment fund of Adriaan Hart de Ruijter, experienced entrepreneur and investor in life sciences. Founded in 2016, Cascara invests in the seed stage of companies that apply technology to prevention, therapy and research. Examples are vaccines, medical devices, pharmaceuticals, imaging, software, medical data, robotics, healthcare services, diagnostics and cell therapy.
CitareTx Investment Partners
Our investment activities are primarily focused on Class II medical devices for which the United States Food and Drug Administration pre-market notification process (i.e. 510(k)) can be utilized as the means to obtain regulatory clearance and begin commercial sale of product. However, we remain opportunistic and consider other investments if certain criteria are present, such as the presence of a strategic partner with a defined exit milestones. Although our team has extensive expertise in the cardiovascular, interventional cardiology, interventional radiology, cardiac surgery, vascular surgery, critical care, consumable product, patient care, and orthopedic markets, we are open to any and all target markets. In addition, we do consider investment opportunities with smaller than typically accepted venture capital market size thresholds.
Civilization Ventures
Civilization Ventures leverages an extensive network of world-class scientists and clinicians (including half a dozen MDs and PhDs), as well as accomplished founders and CEOs from our portfolio companies, to gain access to and understand the leading innovations in our space. Our network is truly global, with key advisors located in Silicon Valley, Cambridge and NY in the US, as well as Europe and Asia. Our international reach and deep domain expertise has empowered us to invest in exponential health technologies and synthetic biology companies worldwide, with founders who have earned advanced degrees from leading academic institutions such as Harvard, Stanford, Berkeley, MIT, Columbia, Oxford, Cambridge, and Caltech, among others. Our core mission is to back truly disruptive innovation that has the potential to advance our civilization.
Decheng Capital
Decheng Capital is a leading investment firm that provides capital and strategic support to early stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence. Located in Shanghai and Silicon Valley, we are a group of dedicated professionals with complementary expertise who have outstanding track records of building highly successful companies globally. Decheng is poised to deliver superior returns for our investors and create value for our entrepreneur partners.
Deerfield Management
Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment and philanthropy—all toward the end goal of cures for disease, improved quality of life and reduced cost of care. As of June 2020, the firm manages nearly $10 billion in assets. Providing value beyond capital, Deerfield generally maintains a combined portfolio of more than 200 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.
Earlybird Venture Capital
Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources, but also strategic and operational support, as well as access to an international network and capital markets. With over EUR 1 billion under management, seven IPOs and 24 trade sales, Earlybird is one of the most successful venture capital firms in Europe.
Elkstone Partners
Elkstone is a Multi-Family Office regulated by the Irish Central Bank to provide investment services including investment portfolio management, and providing compelling investment opportunities in venture, real estate and alternatives.
Endeavour Vision
Endeavour Vision is a leading private equity firm investing in growth-stage medtech and digital health companies. We invest in medical innovation that provides superior clinical benefits for patients or brings significant efficiencies to over-stretched healthcare systems. Our team offers strategic and operational expertise, extensive international experience, and a proven track record of successful exits. Endeavour Vision’s offices are in Geneva, Switzerland and Minneapolis, U.S. For more information, visit www.endeavourvision.com.
Epidarex Capital
Epidarex Capital is a leading transatlantic venture capital firm that invests in early-stage, high growth life science opportunities in under-ventured markets. Epidarex funds ground-breaking research, often building companies from scratch, to address large unmet medical needs with solutions that provide significant benefits to patients.
European Investment Bank
The European Investment Bank is the lending arm of the European Union. The biggest multilateral financial institution in the world and one of the largest providers of climate finance. The EIB works closely with other EU institutions to foster European integration, promote the development of the EU and support EU policies in over 140 countries around the world. The EIB supports small companies through local banks and lend money to innovative start-ups. Mid-cap companies can receive direct support for research and development investments.
European Investment Fund
The mission of the European Investment Fund (EIF) is to improve access to finance for SMEs and small mid-caps in Europe. We do this by supporting emerging and established fund managers with equity investments and by designing debt financing instruments that share the risk taken by financial institutions when they lend to or invest in small businesses. We bring this support closer to entrepreneurs through our extensive network of partners and financial intermediaries in all EU-28 Member States and associated countries in other geographies.
ForMED Ventures
ForMED (Formosa Medical) Ventures invests in early stage companies in the Healthcare and Medical Technology sector; primarily in Israel, Taiwan and the United States. Our mission is to create better healthcare by addressing unmet medical needs and improving quality of life. ForMED Ventures is located in Taiwan, the heart of the Asia-Pacific region. The Taiwanese industrial environment is well-known for its success in precision machinery and ICT industry. The island’s capital market is characterized with MedTech friendly investors, both in the private and public market. ForMED’s location gives our portfolio companies access to the Taiwanese industrial and capital market and opens the door to the whole Asia-Pacific region.
Fortunatus Capital
*Description coming soon!
Fountain Healthcare Partners
We are a venture fund providing risk capital and expertise to ambitious entrepreneurs building outstanding life sciences companies. By limiting the number of active portfolio companies we have the bandwidth to provide more than just capital. Our years of experience help entrepreneurs grow smartly, mitigate risk and expand impact.
Gilde Healthcare
Gilde Healthcare is a specialized European healthcare investor managing two business lines: a venture & growth capital fund and a lower mid-market buy-out fund. It has over €800 million ($1 billion) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcare services across Europe and the US.
Grant Engine
Grant Engine is regularly identified as the leading platform for securing non-dilutive funding. We work directly with you to develop the right, best story to secure funding for your products. We write the grant with your essential inputs. As a team of scientists and entrepreneurs, Grant Engine understands what it takes to build a differentiated product to improve the standard of care to address an unmet clinical need. With win rates at 2 to 4x better than the national average, a proven team, and a focus on advancing differentiated products that improve the standard of care, we partner with select companies who want to save lives.
Hadean Ventures
Hadean Ventures is a life science fund manager that invests in life science companies across Europe with a particular focus on the Nordic region. The funds are backed by leading private and institutional investors.
Hadean Ventures has offices in Oslo and Stockholm and collaborates with world-class academic institutions and start-up hubs across the region.
Hatteras Venture Partners
With over two decades of experience as early stage VC company builders, Hatteras Venture Partners has constructed a risk-mitigated, replicable value creation model. The cutting-edge companies we focus on range from those delivering therapeutic or diagnostic benefits to patients to companies disrupting the status quo in healthcare and accelerating the pace of innovation.
HealthQuest Capital
At HealthQuest, it’s our mission to broadly improve people’s lives through healthcare innovation. We do this by being best-in-class, working with outstanding people, and conducting ourselves ethically and with integrity. We aim to identify and invest in companies that are transforming the healthcare landscape, and generate outsize risk-adjusted returns for our stakeholders. We invest in healthcare transformers: companies that are improving outcomes, or reducing the cost of, and improving the efficiency of delivering healthcare. We invest in innovation broadly across the healthcare spectrum: medical devices and technologies, diagnostics, research tools, digital health, healthcare IT, and innovative services.
HealthTech Capital
HealthTech Capital is a group of private investors dedicated to funding and mentoring new “HealthTech” start ups at the intersection of healthcare and the computer/consumer electronic world. We also organize the HealthTech Conference in the fall on how to build Healthtech and Digital Health companies. Our goal is to invest and mentor capital efficient companies that use new scalable business model to improve the efficiency of healthcare delivery from the hospital to the home.
H.I.G. BioHealth Partners
With $400 million in assets under management, H.I.G. BioHealth Partners invests in a broad range of healthcare companies across multiple sectors and stages of development. Our seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. We invest in companies developing novel products for significant unmet medical needs.
High-Tech Gründerfonds
High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven start-ups. With around EUR 900 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge almost 600 start-ups since 2005. Driven by their expertise, entrepreneurial spirit and passion, its team of experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech start-ups in the fields of digital business models, industrial technology, life sciences, chemistry and related business areas. To date, external investors have injected over EUR 2.4 billion into the HTGF portfolio via more than 1,500 follow-on financing rounds. HTGF has also successfully sold interests in more than 100 companies.
Hunniwell Lake Ventures
Hunniwell Healthcare Fund I invests in extensions of proven technologies within overlooked segments of the medical device space from the heart of Silicon Valley. It provides entrepreneurs with a longer runway to develop a more complete portfolio of products before monetizing their innovations. We leverage our entrepreneurial spirit, operational experience, and global networks to help companies achieve higher profitability earlier, through improved market access, greater capital efficiency in R&D, and lower manufacturing costs.
iGan Partners
Based in Toronto, we partner with exceptional founders focused on commercializing and scaling technological advancements in healthcare. We provide portfolio companies with smart-capital, active support, and access to a network of industry partners and sector specific co-investors to help them grow and succeed. We invest in healthcare because it’s where we think we can have the greatest impact on the world. We believe that despite remarkable progress (e.g., vaccines, imaging, diagnostics, EMRs, minimally invasive surgery etc), we continue to face major challenges in healthcare on a global basis.
Illumina Ventures
Illumina Ventures is an independently managed firm focused on early-stage companies that are pioneering new applications of genomics and enabling precision medicine. We invest in life science tools, clinical diagnostics, therapeutics, and other opportunities to improve human health. Our strategic relationship with Illumina provides us access to the expertise and vision of the world's leading genomics solutions provider. Our team members have decades of entrepreneurial experience in genomics and a passion for improving human health.
imec.xpand
imec.xpand is an independently managed value-add venture capital fund that focuses on hardware-based nanotechnology innovations where imec technology, expertise, network and infrastructure will play a differentiating role.
Industrifonden
Industrifonden is a Nordic venture capital investor, focusing on early stage technology and life science companies with international potential. Industrifonden is an evergreen fund with SEK 5 billion ($600 m) in assets, and we like to work long term with the team we invest in. The tech portfolio currently consists of 25 companies, among those Barnebys, Soundtrack Your Brand and Fishbrain. The life science portfolio currently represents 14 companies, among those AMRA, BONESUPPORT and Oncopeptides.
INKEF Capital
INKEF Capital helps early stage companies reach their full potential. We back mission-driven entrepreneurs who are passionate about the problem they are solving and are ready to take the next step to grow their business. Working side-by-side with these visionaries makes us incredibly optimistic about the future. We are always on the lookout for interesting new companies led by ambitious entrepreneurs at the Series A stage. If you are a life sciences, digital health or tech entrepreneur and believe that we could be the right partner, please do not hesitate to contact us.
Innogest
Innogest is a Venture Capital firm focused on seed and early stage ventures, with more than € 200 milion of capital under management. We have over 100 years of cumulative professional experience in the digital and the healthcare fields. Innogest invests in high potential companies through a direct share in their equity and pays special attention to market potential and size. Innogest leverages its extensive network of contacts, working alongside its partners through its offices in Turin, Milan and San Francisco. Our mission is to generate high-level returns for our investors by turning entrepreneurship and technology into fast-growing and successful companies.
Innovation Industries
Innovation Industries is an independent venture capital fund that combines company-building and venture investment under one roof. We use a market-driven approach to create long-term value in high technology start-up and scale-up companies. Our partnerships with all Dutch technical universities and applied research institutes (TNO) provide us with unparalleled access to knowledge and technologies.
Intuitive Ventures
*Description coming soon!
IPF Partners
IPF Partners is a leading alternative financing provider focused on the healthcare sector. IPF Partners invests directly in emerging commercial stage pharma/biotech, medtech, diagnostics and IT healthcare companies. IPF Partners provides customised low- to non-dilutive debt and equity financing to market leading healthcare companies. The focus is on innovating products at commercial stage with a high potential in attractive markets. Typical deal size ranges from €5-20m+ over a 3- to 6-year duration.
IP Group
IP Group aims to address some of the world’s most pressing challenges through the companies we back, allowing us to generate positive social and environmental impact alongside financial returns.
Joyance Partners
Joyance Partners is the first venture fund focused on finding and growing new companies that deliver Delightful Moments derived from science. Delightful Moments are part of all human experience: the small, but powerful, separations from the daily humdrum when we feel stronger, calmer, more joyful, more in control, more distant from pain and anxiety. Now, emerging science and technology present the potential to deliver these experiences. Science can help individuals be a bit happier, which can lead to greater health. Or a little healthier, which can lead to greater potential for happiness. It is a new, transformative cycle of human experience.
KCK Group
KCK invests in medical technology companies with differentiated products that are well positioned to disrupt or create large markets utilizing strong management teams and business models. Our primary focus for new investments is on later stage venture and growth capital opportunities.
Kettlebeck Ventures
Kettlebeck Ventures was formed out of our passion to increase access to healthcare, drive clinical innovation and improve patient outcomes. Our group has deep expertise in science, medicine and the healthcare industry. We want to apply our industry knowledge, leverage connections and inject capital to tackle challenges and drive innovation in healthcare.
Kleiner Perkins
For five decades, Kleiner Perkins has made history by partnering with some of the most ingenious and forward-thinking founders in technology and life sciences. Through twenty venture funds and four growth funds we’ve invested $10 billion in hundreds of companies including pioneers such as Amazon, Genentech, and Google. Today, Kleiner Perkins continues to help founders and their bold ideas make history investing in companies like Desktop Metal, IronNet, Ring, Spotify, Slack, and UiPath.
Kreos Capital
As the pioneer growth debt provider across the UK, Western Europe, Scandinavia and Israel, Kreos has completed over 570 portfolio company transactions and committed more than €2.6 billion in 16 different countries. Kreos has a proven track record of adding value to portfolio companies and helping them to grow with additional capital and flexibility throughout their business cycle whilst working closely with both the portfolio company management team and their equity sponsors.
LFE Capital
LFE Capital is a growth equity fund manager that invests in second stage companies in the health and wellness sectors, with a focus on businesses with female ownership and management. LFE provides expansion capital and operating support to businesses with revenues of $2-20 million. LFE is flexible and takes minority and control positions in its portfolio companies and works actively with management teams to execute growth plans. The firm provides equity and/or debt. Key geographies include the Midwest, the Southeast, and Rocky Mountain regions but LFE will consider other geographies within the continental U.S.
Life Science Angels
Life Science Angels is a not-for-profit corporation with 130-150 accredited investor members, 12-18 highly qualified Fellows, and 12-15 Sponsor organizations. We take no carry or management fees on investments. We do not charge companies any fees. For each investment, we write one check and sign one set of paperwork and so appear as a single investor on portfolio company capitalization charts. Our separate individual members pool their holdings through special purpose LLCs. We prefer active investment, generally providing a board member or Observer, or some other form of strategic or operational advisor to portfolio companies. We will invest in companies outside of our geographic area, especially when those companies are supported by local angel groups who we know or have invested alongside.
Longitude Capital
Longitude Capital specializes in making venture growth investments in biotechnology, medical technology, and health solutions companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs. We invest in both privately held and publicly traded companies through a variety of investment approaches. Since 2006, Longitude Capital has raised over $1.2 billion across three funds and demonstrated an ability to source, manage and exit attractive investments across multiple market cycles.
LSP Life Science Partners
LSP is one of Europe’s largest and most experienced healthcare investment firms. With a track record going back more than 30 years, we have built up an investment house that is dedicated to only one task: seeking, nurturing and growing healthcare investment opportunities with the potential to have a positive impact on society. We believe such opportunities create the most value for all parties.
Lumira Ventures
Over more than two decades, our firm has invested over $1B via multiple investment funds. We leverage the lessons learned from helping create, finance and build over 100 innovative healthcare companies. The areas of medical need being tackled by our companies include diabetes, Alzheimer’s, vision loss, heart failure, asthma, infectious disease and others that impact the daily lives of over 1 billion people worldwide. Stage: Mix of early, clinical and revenue stage companies that are both privately held and publicly traded. Sectors: Biotechnology, medical technologies, digital health and consumer healthcare solutions.
Maxim Ventures
Maxim Ventures is dedicated to helping innovative healthcare and life science startups bridge the gap between the analog measured world and the digital computational world, and creating thriving businesses along the way. As healthcare costs rise and populations age, how can we deliver the level of care that people require? Whether our goal is to stay fit, receive early warning signs, monitor chronic conditions, accelerate recovery, or age in place, we all need better ways to monitor our health. By doing things like recording a heartbeat, monitoring the environment, measuring blood-glucose levels, and augmenting people's senses, technology plays a critical role in delivering the insights to make all of this possible.
MBX Capital
MBX Capital is a boutique venture capital firm focused on early-stage healthcare and life sciences companies. The firm's portfolio acceleration network, Atom, includes over one thousand senior industry executives, physicians, and scientists who collaborate with MBX to catalyze its partner companies. MBX is a flexible investor, both leading rounds and participating actively in syndicates, with an emphasis on companies who are serving the needs of neglected communities or developing technologies that will accelerate scientific discovery. The firm has offices in New York and Los Angeles and considers investment opportunities globally.
McGeever
McGeever is a family office positioned to establish, administer, and govern our unique financial and philanthropic values and goals. Through private investment management and charitable giving, the McGeever office is a perpetual entity focused on preserving legacy values, wealth management, and the lifestyle creation of future generations. Our legacy is to preserve family and individual vision, pursue opportunity, and create value. Our family’s values will continue to transition generationally through our guiding principles of managing all family businesses, investments, and philanthropic endeavors with: integrity, dedication, and compassion. Headquartered in North Carolina, the McGeever family office has partnered with entrepreneurs worldwide.
Medtech Convergence Fund
Medtech Convergence Fund (MCF) is a seed and early-stage venture capital fund committed to helping entrepreneurs, healthcare professionals and inventors build innovative medical technology companies. MCF’s fund strategy is focused on the increasing convergence of medical technology with software, telecommunications, and new service models to create solutions to some of the most significant health challenges. The MCF team leverages decades of medtech investing and operating experience to help entrepreneurs succeed from the earliest phases of product development.
MedTech Venture Partners
At MedTech Venture Partners, we fund and support medical technology entrepreneurs. Combined, our team has overseen the conception, development, and launch of over 30 medical devices and diagnostics products. We scaled early stage device businesses, operated large ones, we have extensive clinical and regulatory experience globally, and participated in buying and selling technologies, products, and companies. We believe our experience allows us to better understand device entrepreneurs and help them succeed.
MEDTEQ
Thanks to our expertise in R&D in health technologies, we exclusively invest in companies that are focused on developing technological solutions for the benefit of patients.
Mighty Capital
Mighty Capital is an early-growth Silicon Valley venture capital firm. We look for companies with a strong leadership team, proven product-market fit, and a clear go-to-market strategy. We are investors in Airbnb, MissionBio, among others. Amplitude, one of our portfolio companies, says that our network helped them generate millions in dollars of revenue and calls us the “best value for the dollar invested.”
MVM Partners
MVM has been investing in high growth healthcare businesses since 1997. We have a broad, global, investment remit including medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, and digital health, supported by our investment teams in Boston and London.
NEA New Enterprise Associates
New Enterprise Associates, Inc. (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. With more than $23 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’s lifecycle, from seed stage through IPO. The firm's long track record of successful investing includes more than 230 portfolio company IPOs and more than 390 acquisitions.
Neue Fund
Neue Fund is a science-driven, early-stage venture capital firm that invests in game-changing founders and startups in healthcare, life sciences, biotechnology and other deep technology applications focused on improving the human condition. We deploy the scientific method and evidence-based approaches to analyze and source the most promising innovations that can be scaled to meet the most pressing needs of our society today.
Norgine Ventures
Norgine Ventures was started in 2012 to diversify Norgine’s activities and foster innovation in the healthcare sector. Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US. To date, Norgine Ventures has invested in a number of businesses, including specialty pharma, diagnostic and medical device companies, at various stages of their life cycle, both in Europe and in the US.
OCV Partners
OCV is a Los Angeles based venture fund that to date has raised approximately $260.8M. OCV invests in, owns, and operates companies with differentiated technologies and compelling target markets, with the overriding objective of creating sustainable long-term value. As value-additive partners focused on innovation, operational efficiency, and sound management, we have a proven track record helping businesses realize their true potential. Our core focus sectors include: information technology, cloud businesses, e-commerce, media & telecommunications, life sciences & healthcare, and clean technology.
Olive Tree Ventures
We’re an early stage and growth health venture fund managing over $155 million in assets. Like our Olive Tree symbolism, we’re both fruitful and enduring, with strong roots that support continuous growth year after year. Our partners have collectively generated over $4 billion in exit revenue over the last 10 years.
OSF Ventures
OSF Ventures invests financially and operationally in opportunities that will improve patient outcomes, enhance patient experience and reduce the cost of health care. We believe in not only investing financially, but also strategically through comprehensive collaboration.
Palo Alto Investors
Palo Alto Investors LP (PAI) is a physician-led investment firm conducting deep, fundamental research since 1989. We apply our expertise, original insight and exhaustive research to identify long-term investments for high net worth and institutional investors.
Panakes Partners
Panakes Partners is a Venture Capital investor that finances medical companies, early stage startup and SMEs, with extremely promising products and great ambition, in Europe and Israel. Thanks to our strong entrepreneurial and financial experiences we provide more than capital, and we aim to work together with entrepreneurs to develop successful businesses as an active and well-connected investor. We also have strong relationship with selected industrial partners to help companies to accelerate their development. We seek and help to grow Medtech companies with the potential to have a positive impact on society. We believe such opportunities create the most value for all parties.
Pangaea Ventures
Pangaea is the world leader in advanced materials venture capital. We invest in start-up companies using advanced materials to make our world better by creating products to tackle tough problems in hard tech.
Peppermint Venture Partners
Peppermint Venture Partners (PVP), is a private venture capital firm based in Berlin, Germany, investing in early-stage healthcare companies across Europe with a focus on medical device, digital health and platform technology companies.
PMV
PMV is a do and dare company that is shaping the future of the Flemish economy. It finances promising companies from the very start up to and including growth and internationalization. With and for the government and other partners, she realizes projects that are important for prosperity and well-being in Flanders.
Providence Ventures
Providence Ventures (PV) manages $300 million of venture capital across two funds on behalf of Providence Health, which operates 51 hospitals and 800+ clinics across seven states, making it among the top 5 largest health systems in the United States. The funds are designed to achieve venture class returns through direct investments in innovative healthcare companies that improve quality and convenience, lower cost, and improve health outcomes. PV offers investment capital, combined with health system and plan expertise, to companies addressing existing and emerging pain points in healthcare. PV partners with our portfolio companies to refine existing solutions, while expanding their adoption within and beyond Providence.
Questa Capital
Questa Capital is a healthcare venture growth equity firm that invests in breakout growth companies. We seek out disruptive business models that improve lives and provide better quality and more efficient care. We partner with superior management teams to help build innovative market leaders.
Revelation Partners
Revelation Partners invests across healthcare sectors with a focus on commercial companies with proven business models or companies with novel technologies that have clear clinical and regulatory pathways. We actively invest in the following healthcare verticals-medical-devices, biopharmaceuticals, healthcare IT, and healthcare services. We typically invest between $5 million and $30 million. We have the ability to do larger deals in conjunction with our limited partners and have done deals as large as $100 million. Revelation Partners manages several funds dedicated to secondary investing in healthcare. In total, the investment team manages over $550 million of committed capital.
Rhia Ventures
We’re a women-led social investment company who use our skills as investors and voices as advocates to create sustainable change in Women’s Reproductive Health. Because when women are empowered, given choice, and access, the impact benefits their families, communities, and the entire economy.
River Cities Capital Funds
River Cities Capital is one of the most active and experienced growth equity funds in healthcare and information technology (IT). With nearly $800 million raised to date and more than 125 investments made, we have established ourselves as a preferred partner among the entrepreneurial and private equity communities. The firm is currently seeking new investments for its $200M Fund VI.
RiverVest Venture Partners
Improving the lives of patients, supporting entrepreneurs, and earning the trust of investors through science, strategy, and innovation. RiverVest is a leading venture capital firm building life science companies to address significant unmet medical needs.
Santé
Santé invests at the leading edge of innovation in healthcare and technology. We manage over a half-billion dollars of capital in two separate strategies. Combining extensive healthcare industry experience with deep scientific and technology expertise, we pursue innovative new opportunities with attractive potential returns.
Seroba
Seroba is a European life sciences venture capital firm focused on investing in winning innovations in biotech and medtech. The team has deep investment and industry experience enabling Seroba to help entrepreneurs realise their ambitions whilst creating value for investors. The firm has three funds under management and has built a portfolio of investee companies across multiple indications. Seroba partners with entrepreneurs to create and build businesses around extraordinary science. Follow our story at www.seroba-lifesciences.com.
Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm specialized in Life Sciences. Based in Paris, France, with offices in London and Milan, the firm brings together a team of over 40 professionals from all over Europe, the U.S., and Asia. The firm focuses on paradigm-shifting technologies alongside visionary entrepreneurs. Sofinnova Partners invests across the Life Sciences value chain as a lead or cornerstone investor, from very early-stage opportunities to late-stage/public companies. It has backed over 500 companies over five decades, creating market leaders around the globe. Today, Sofinnova Partners has over €2 billion under management.
Sonder Capital
The Sonder Capital team has spent our entire careers dedicated to the medtech community. As entrepreneurs, operators and investors we’ve built, funded, and advised companies creating entire new categories of healthcare. Our goal is to partner with entrepreneurs who have a passion for inventing technologies capable of transforming healthcare in the medical device, diagnostic and healthtech sectors. We commit our energy and capital early (seed or Series A) and maintain guidance and support from inception to acquisition or IPO.
Springhood Ventures
Springhood backs young companies working to significantly improve health outcomes of children. We support passionate entrepreneurs developing strong science with a clear commercial pathway. Young companies developing solutions for kids have unique challenges. We meet those challenges head on by providing the capital and resources that will help the best of these companies navigate the startup journey - knowing that we are uniquely positioned to do this. Springhood supports companies in their seed-stage (typically less than $2 million of outside capital raised).
Strategic Healthcare Investment Partners
We focus on medical technology investments in companies targeting large unmet clinical needs. We will invest in high growth areas and in companies solving major clinical problems while balancing that with focused capital efficient development plans. We take a balanced approach in building our portfolio with some early stage investments, where the prior seed stage investment has proved the feasibility of a concept, and some later stage investments, where clinical data has shown efficacy and the company is in a “scale-up for commercialization” mode.
SV Health Investors
SV Health Investors is a specialist healthcare fund manager, investing across stages, geographic regions, and sectors, with expertise spanning biotechnology, dementia, healthcare growth, healthcare technology and public equities. Alongside our core funds, SV manages the Dementia Discovery Fund, focused on discovering and developing novel therapeutics for dementia, and the International Biotechnology Trust plc, a publicly-traded investment trust.
The Foundry
The Foundry, LLC is the premier medical device company incubator. We work with inventors to rapidly transform their concepts into companies by providing an incomparable combination of leadership, an experienced, multi-disciplinary team, a state-of-the-art facility and an extensive funding network. The Foundry Team is comprised of veteran medical device entrepreneurs and investors with real world experience—and success—in developing world class medical device companies.
Thuja Capital
Thuja Capital is an early-stage venture capital firm located in Utrecht, The Netherlands. We invest in product focused companies that aim to have true impact for patients and doctors alike, as demonstrated in clinical studies to enable a health claim. Hence most of our ventures are active in the field of therapeutics, medical devices and digital health. Not only do we invest, we also take an active role in helping the company to become successful, by leveraging our extensive network and by bringing our own experience to the table.
Vensana Capital
Vensana was launched in 2019 by Justin Klein and Kirk Nielsen with the support of Versant Ventures. Vensana is actively investing in clinical development and commercial stage companies across the medtech sector, including medical devices, diagnostics and data science, drug delivery, digital health, and tech-enabled services. We expect to commit our $225 million inaugural fund to a dozen such companies, with typical investments in the range of $10-30 million.
Venture Investors
Venture Investors seeks the next big things in healthcare. Based in the Midwest with open access to renowned research universities, and the vibrant communities that surround them, we target, uncover, and invest in extraordinary ideas that will shape the future of health and wellness. With decades of proven success, we’re fueling the future of what’s driving healthcare. Today, we have $275 million in assets under management.
Viscogliosi Brothers
VB focuses on creating tangible solutions that develop into sustainable businesses. We invest in companies focused on addressing unmet needs, while saving the healthcare system money. Our focus goes beyond serving the population today; we strive to create a better healthcare environment for future generations.
Vivo Capital
Vivo Capital is a global investment firm focused on healthcare. Vivo has approximately $4.3 billion in assets under management, invested in over 250 public and private companies worldwide. The firm is headquartered in Palo Alto, California, with additional offices in Asia. The Vivo team consists of more than 50 multi-disciplinary professionals, including, physicians, scientists, entrepreneurs, operating executives, and industry experts. Vivo provides a multi-fund investment platform, covering growth equity, private equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets.
WaveEdge Capital
WaveEdge Capital is a global, boutique merchant bank based in San Mateo, CA that delivers world-class strategic and financial services to emerging growth companies in the healthcare and life science sectors.
Wellington Partners
Since 1998, Wellington Partners has been a leading European Venture Capital firm investing in early- and growth-stage Life Science companies, active in the fields of Therapeutics, Medical Technology, Diagnostics, Digital Health and Industrial Biotechnology. Managing and investing out of funds WPLS-III, WPLS-IV and WPLS-V. More than €400m of funds raised dedicated to Life Sciences. Investment Team with strong clinical, scientific and operational backgrounds. Europe, special circumstances US, leader in Germany. Seed to late-stage, private companies most of the time. Ticket sizes from €2m up to €20m over the life of the investment.
Westlake Accelerator
Westlake Cross Border Innovation Accelerator aims at building a superior cross-border innovation eco-system, and bridging innovative projects, creative talents and venture resources. Our program helps early-and-growth stage technology-driven startups building their future from 0 to 1 in the fields of Healthcare, Fintech, Big Data, IoTs, Artificial Intelligence, and Robotics, etc.
